Corbenic Partners’s Sanofi SNY Stock Holding History

Corbenic Partners’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-150	Closed	-$6K	–	220
2016 Q2	$6K	Buy	+150	New	+$6.15K	0.01%	142
2016 Q1	–	Sell	-493	Closed	-$21K	–	191
2015 Q4	$21K	Hold	493	–	–	0.02%	99
2015 Q3	$23K	Hold	493	–	–	0.02%	85
2015 Q2	$24K	Hold	493	–	–	0.02%	72
2015 Q1	$24K	Sell	493 -24	-5%	-$1.15K	0.02%	80
2014 Q4	$24K	Buy	+517	New	+$25.1K	0.02%	83

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Corbenic Partners's SNY Position: Q3 2016 in Review

Corbenic Partners sold out of Sanofi (SNY) in Q3 2016, closing a stake of 150 shares — an estimated $6K sold.

Corbenic Partners first reported a position in SNY in Q4 2014 and held it in 6 quarters. The position peaked at $24K in Q2 2015. 450 funds tracked by Wall St. Rank hold SNY as of Q3 2016.

Corbenic Partners reported no remaining Sanofi position as of Q3 2016 after selling out during the quarter.
Corbenic Partners sold 150 Sanofi shares in Q3 2016, an estimated $6K.
Corbenic Partners first reported a position in Sanofi in Q4 2014 and held it in 6 quarters.
Corbenic Partners's Sanofi position peaked at $24K in Q2 2015.
450 funds tracked by Wall St. Rank held Sanofi as of Q3 2016.

Based on Corbenic Partners's 13F filing for Q3 2016, filed 27 Oct 2016.